Q2 2026 revenue rose 8.7% year-over-year to $4,368 million, with net income at $256 million and diluted EPS at $1.53. Both Commercial and Research & Development Solutions segments posted strong growth, and the company increased its share repurchase authorization while maintaining robust liquidity and compliance with debt covenants.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.